Structure

Physi-Chem Properties

Molecular Weight:  634.27
Volume:  646.603
LogP:  6.347
LogD:  3.832
LogS:  -7.403
# Rotatable Bonds:  3
TPSA:  78.93
# H-Bond Aceptor:  9
# H-Bond Donor:  0
# Rings:  9
# Heavy Atoms:  9

MedChem Properties

QED Drug-Likeness Score:  0.239
Synthetic Accessibility Score:  5.862
Fsp3:  0.342
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.663
MDCK Permeability:  3.061553798033856e-05
Pgp-inhibitor:  1.0
Pgp-substrate:  0.973
Human Intestinal Absorption (HIA):  0.002
20% Bioavailability (F20%):  0.202
30% Bioavailability (F30%):  0.844

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.069
Plasma Protein Binding (PPB):  91.2851791381836%
Volume Distribution (VD):  0.622
Pgp-substrate:  3.3228580951690674%

ADMET: Metabolism

CYP1A2-inhibitor:  0.106
CYP1A2-substrate:  0.926
CYP2C19-inhibitor:  0.74
CYP2C19-substrate:  0.943
CYP2C9-inhibitor:  0.241
CYP2C9-substrate:  0.913
CYP2D6-inhibitor:  0.164
CYP2D6-substrate:  0.912
CYP3A4-inhibitor:  0.953
CYP3A4-substrate:  0.95

ADMET: Excretion

Clearance (CL):  10.53
Half-life (T1/2):  0.112

ADMET: Toxicity

hERG Blockers:  0.88
Human Hepatotoxicity (H-HT):  0.135
Drug-inuced Liver Injury (DILI):  0.7
AMES Toxicity:  0.265
Rat Oral Acute Toxicity:  0.403
Maximum Recommended Daily Dose:  0.995
Skin Sensitization:  0.151
Carcinogencity:  0.618
Eye Corrosion:  0.003
Eye Irritation:  0.005
Respiratory Toxicity:  0.84

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC473716

Natural Product ID:  NPC473716
Common Name*:   FACPTWNXIVCGNY-KYJUHHDHSA-N
IUPAC Name:   n.a.
Synonyms:   (-)-Curicycleatjenine
Standard InCHIKey:  FACPTWNXIVCGNY-KYJUHHDHSA-N
Standard InCHI:  InChI=1S/C38H38N2O7/c1-22(41)40-14-12-25-18-32(43-4)34-20-28(25)29(40)15-23-5-8-27(9-6-23)46-38-36-26(19-35-37(38)45-21-44-35)11-13-39(2)30(36)16-24-7-10-31(42-3)33(17-24)47-34/h5-10,17-20,29-30H,11-16,21H2,1-4H3/t29-,30-/m0/s1
SMILES:  CC(=O)N1CCC2=CC(=C3C=C2C1CC4=CC=C(C=C4)OC5=C6C(CC7=CC(=C(C=C7)OC)O3)N(CCC6=CC8=C5OCO8)C)OC
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL449980
PubChem CID:   44559025
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0004603] Organic oxygen compounds
      • [CHEMONTID:0000323] Organooxygen compounds
        • [CHEMONTID:0000254] Ethers
          • [CHEMONTID:0002463] Diarylethers

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO14592 Cyclea atjehensis Species Menispermaceae Eukaryota n.a. n.a. n.a. Database[Title]
NPO14592 Cyclea atjehensis Species Menispermaceae Eukaryota leaves Thai n.a. Database[Title]
NPO14592 Cyclea atjehensis Species Menispermaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT91 Cell Line KB Homo sapiens ED50 = 8360.0 nM PMID[501259]
NPT6 Organism Plasmodium falciparum Plasmodium falciparum IC50 = 2320.0 nM PMID[501259]
NPT2 Others Unspecified Selectivity Index = 3.6 n.a. PMID[501259]
NPT6 Organism Plasmodium falciparum Plasmodium falciparum IC50 = 1200.0 nM PMID[501259]
NPT2 Others Unspecified Selectivity Index = 7.0 n.a. PMID[501259]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC473716 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC475597
0.9647 High Similarity NPC299990
0.9647 High Similarity NPC73492
0.9605 High Similarity NPC475654
0.9371 High Similarity NPC281581
0.9266 High Similarity NPC24260
0.9235 High Similarity NPC317439
0.9235 High Similarity NPC227060
0.9235 High Similarity NPC63646
0.9235 High Similarity NPC317145
0.9235 High Similarity NPC76682
0.9235 High Similarity NPC198498
0.9235 High Similarity NPC10908
0.9235 High Similarity NPC115284
0.9235 High Similarity NPC276890
0.9181 High Similarity NPC129518
0.9181 High Similarity NPC251580
0.9181 High Similarity NPC41376
0.9181 High Similarity NPC12424
0.9075 High Similarity NPC293093
0.8971 High Similarity NPC475479
0.8971 High Similarity NPC243454
0.892 High Similarity NPC239584
0.887 High Similarity NPC229373
0.887 High Similarity NPC181796
0.887 High Similarity NPC290005
0.887 High Similarity NPC328155
0.887 High Similarity NPC185639
0.887 High Similarity NPC182052
0.887 High Similarity NPC54654
0.887 High Similarity NPC7715
0.887 High Similarity NPC222661
0.887 High Similarity NPC217748
0.887 High Similarity NPC49075
0.887 High Similarity NPC290582
0.887 High Similarity NPC239824
0.887 High Similarity NPC42663
0.887 High Similarity NPC258657
0.887 High Similarity NPC271013
0.887 High Similarity NPC90998
0.887 High Similarity NPC104196
0.887 High Similarity NPC251735
0.887 High Similarity NPC223690
0.887 High Similarity NPC285931
0.887 High Similarity NPC311973
0.887 High Similarity NPC8836
0.887 High Similarity NPC279228
0.887 High Similarity NPC15414
0.882 High Similarity NPC254441
0.882 High Similarity NPC167116
0.882 High Similarity NPC274716
0.8814 High Similarity NPC286119
0.8771 High Similarity NPC95426
0.8771 High Similarity NPC302245
0.8771 High Similarity NPC16357
0.8764 High Similarity NPC30779
0.8722 High Similarity NPC139783
0.8722 High Similarity NPC116465
0.8722 High Similarity NPC65312
0.8722 High Similarity NPC212237
0.8715 High Similarity NPC302275
0.8674 High Similarity NPC275680
0.8674 High Similarity NPC22115
0.8667 High Similarity NPC249996
0.8626 High Similarity NPC175890
0.8626 High Similarity NPC48490
0.8626 High Similarity NPC82457
0.8626 High Similarity NPC274661
0.8626 High Similarity NPC206900
0.8626 High Similarity NPC11296
0.8603 High Similarity NPC195538
0.8588 High Similarity NPC247639
0.8588 High Similarity NPC25084
0.8579 High Similarity NPC60295
0.8579 High Similarity NPC191132
0.8556 High Similarity NPC476202
0.8529 High Similarity NPC216459
0.8529 High Similarity NPC41178
0.8529 High Similarity NPC138487
0.8516 High Similarity NPC14507
0.8516 High Similarity NPC47077
0.8486 Intermediate Similarity NPC256124
0.848 Intermediate Similarity NPC146288
0.8475 Intermediate Similarity NPC149090
0.8475 Intermediate Similarity NPC19520
0.8432 Intermediate Similarity NPC478093
0.8387 Intermediate Similarity NPC473589
0.8387 Intermediate Similarity NPC30182
0.8387 Intermediate Similarity NPC478092
0.8387 Intermediate Similarity NPC478091
0.8372 Intermediate Similarity NPC234392
0.8372 Intermediate Similarity NPC31311
0.8371 Intermediate Similarity NPC10871
0.8362 Intermediate Similarity NPC241055
0.8343 Intermediate Similarity NPC475393
0.8324 Intermediate Similarity NPC82763
0.8315 Intermediate Similarity NPC75958
0.8289 Intermediate Similarity NPC85381
0.828 Intermediate Similarity NPC318805
0.828 Intermediate Similarity NPC41122
0.827 Intermediate Similarity NPC237579
0.8249 Intermediate Similarity NPC268503
0.8249 Intermediate Similarity NPC317272
0.8249 Intermediate Similarity NPC256012
0.8249 Intermediate Similarity NPC42549
0.8249 Intermediate Similarity NPC264850
0.8249 Intermediate Similarity NPC13916
0.8249 Intermediate Similarity NPC250846
0.8249 Intermediate Similarity NPC24264
0.8249 Intermediate Similarity NPC240841
0.8249 Intermediate Similarity NPC476432
0.8232 Intermediate Similarity NPC38964
0.8222 Intermediate Similarity NPC2314
0.8202 Intermediate Similarity NPC247389
0.8201 Intermediate Similarity NPC234318
0.8198 Intermediate Similarity NPC233029
0.8198 Intermediate Similarity NPC210148
0.8197 Intermediate Similarity NPC32413
0.8197 Intermediate Similarity NPC474506
0.8192 Intermediate Similarity NPC16805
0.8192 Intermediate Similarity NPC225774
0.8192 Intermediate Similarity NPC232514
0.8192 Intermediate Similarity NPC302527
0.8192 Intermediate Similarity NPC167546
0.8192 Intermediate Similarity NPC24465
0.8192 Intermediate Similarity NPC276944
0.8192 Intermediate Similarity NPC238530
0.8187 Intermediate Similarity NPC23219
0.8176 Intermediate Similarity NPC59907
0.8176 Intermediate Similarity NPC475959
0.8176 Intermediate Similarity NPC37144
0.8172 Intermediate Similarity NPC208890
0.8156 Intermediate Similarity NPC204908
0.8156 Intermediate Similarity NPC83198
0.815 Intermediate Similarity NPC82056
0.8148 Intermediate Similarity NPC477258
0.8146 Intermediate Similarity NPC219341
0.8142 Intermediate Similarity NPC258695
0.8142 Intermediate Similarity NPC470879
0.8135 Intermediate Similarity NPC254581
0.8132 Intermediate Similarity NPC112575
0.8118 Intermediate Similarity NPC476144
0.8118 Intermediate Similarity NPC477259
0.8118 Intermediate Similarity NPC210437
0.8118 Intermediate Similarity NPC169387
0.8118 Intermediate Similarity NPC51957
0.8118 Intermediate Similarity NPC106295
0.8118 Intermediate Similarity NPC16107
0.8101 Intermediate Similarity NPC210918
0.8095 Intermediate Similarity NPC471113
0.809 Intermediate Similarity NPC168409
0.807 Intermediate Similarity NPC7467
0.8054 Intermediate Similarity NPC116284
0.8043 Intermediate Similarity NPC244554
0.8023 Intermediate Similarity NPC306902
0.8023 Intermediate Similarity NPC232924
0.8023 Intermediate Similarity NPC266753
0.8023 Intermediate Similarity NPC160298
0.8023 Intermediate Similarity NPC477559
0.8022 Intermediate Similarity NPC152680
0.8022 Intermediate Similarity NPC190783
0.8022 Intermediate Similarity NPC232386
0.8021 Intermediate Similarity NPC214116
0.8 Intermediate Similarity NPC123323
0.8 Intermediate Similarity NPC93593
0.7989 Intermediate Similarity NPC148693
0.7989 Intermediate Similarity NPC180306
0.7989 Intermediate Similarity NPC231198
0.7989 Intermediate Similarity NPC294790
0.7989 Intermediate Similarity NPC118633
0.7967 Intermediate Similarity NPC65403
0.7967 Intermediate Similarity NPC475215
0.7967 Intermediate Similarity NPC108434
0.7966 Intermediate Similarity NPC477080
0.7966 Intermediate Similarity NPC111485
0.7946 Intermediate Similarity NPC220961
0.7926 Intermediate Similarity NPC57036
0.7912 Intermediate Similarity NPC6152
0.7901 Intermediate Similarity NPC474324
0.7901 Intermediate Similarity NPC57812
0.7898 Intermediate Similarity NPC244112
0.7892 Intermediate Similarity NPC114364
0.7892 Intermediate Similarity NPC320223
0.7884 Intermediate Similarity NPC476576
0.7884 Intermediate Similarity NPC186546
0.7882 Intermediate Similarity NPC476567
0.7882 Intermediate Similarity NPC128019
0.7882 Intermediate Similarity NPC136860
0.788 Intermediate Similarity NPC229166
0.788 Intermediate Similarity NPC128560
0.788 Intermediate Similarity NPC49353
0.788 Intermediate Similarity NPC199465
0.7872 Intermediate Similarity NPC9867
0.7865 Intermediate Similarity NPC106786
0.7857 Intermediate Similarity NPC475845
0.7838 Intermediate Similarity NPC241704
0.7833 Intermediate Similarity NPC59567
0.7824 Intermediate Similarity NPC24228
0.7814 Intermediate Similarity NPC474708
0.7809 Intermediate Similarity NPC476572

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC473716 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9235 High Similarity NPD8251 Approved
0.9235 High Similarity NPD8099 Discontinued
0.9235 High Similarity NPD8252 Approved
0.9181 High Similarity NPD8156 Discontinued
0.887 High Similarity NPD8053 Approved
0.887 High Similarity NPD8054 Approved
0.8307 Intermediate Similarity NPD8095 Phase 1
0.8148 Intermediate Similarity NPD7667 Clinical (unspecified phase)
0.8118 Intermediate Similarity NPD4584 Approved
0.8068 Intermediate Similarity NPD6788 Approved
0.7806 Intermediate Similarity NPD5005 Approved
0.7806 Intermediate Similarity NPD5006 Approved
0.7765 Intermediate Similarity NPD4664 Clinical (unspecified phase)
0.7697 Intermediate Similarity NPD7298 Approved
0.7663 Intermediate Similarity NPD4481 Phase 3
0.766 Intermediate Similarity NPD8453 Clinical (unspecified phase)
0.7634 Intermediate Similarity NPD5312 Approved
0.7634 Intermediate Similarity NPD5313 Approved
0.7627 Intermediate Similarity NPD7261 Clinical (unspecified phase)
0.7602 Intermediate Similarity NPD4420 Approved
0.7554 Intermediate Similarity NPD6071 Discontinued
0.7554 Intermediate Similarity NPD4166 Phase 2
0.7542 Intermediate Similarity NPD4772 Phase 2
0.7542 Intermediate Similarity NPD4773 Phase 2
0.7541 Intermediate Similarity NPD5677 Discontinued
0.7526 Intermediate Similarity NPD7281 Phase 3
0.7526 Intermediate Similarity NPD7280 Phase 3
0.75 Intermediate Similarity NPD6107 Approved
0.7486 Intermediate Similarity NPD6783 Clinical (unspecified phase)
0.7461 Intermediate Similarity NPD7906 Approved
0.7459 Intermediate Similarity NPD3051 Approved
0.7429 Intermediate Similarity NPD5084 Clinical (unspecified phase)
0.7416 Intermediate Similarity NPD3640 Phase 3
0.7416 Intermediate Similarity NPD3641 Approved
0.7416 Intermediate Similarity NPD3639 Approved
0.7401 Intermediate Similarity NPD1424 Approved
0.7384 Intermediate Similarity NPD6028 Clinical (unspecified phase)
0.7384 Intermediate Similarity NPD6029 Clinical (unspecified phase)
0.7382 Intermediate Similarity NPD7549 Discontinued
0.7363 Intermediate Similarity NPD6818 Clinical (unspecified phase)
0.7337 Intermediate Similarity NPD7833 Phase 2
0.7337 Intermediate Similarity NPD7831 Phase 2
0.7337 Intermediate Similarity NPD7832 Clinical (unspecified phase)
0.7333 Intermediate Similarity NPD8318 Clinical (unspecified phase)
0.733 Intermediate Similarity NPD5307 Clinical (unspecified phase)
0.7326 Intermediate Similarity NPD2969 Approved
0.7326 Intermediate Similarity NPD2970 Approved
0.7322 Intermediate Similarity NPD2560 Approved
0.7322 Intermediate Similarity NPD2563 Approved
0.7318 Intermediate Similarity NPD6031 Approved
0.7318 Intermediate Similarity NPD6030 Approved
0.7316 Intermediate Similarity NPD3885 Approved
0.7306 Intermediate Similarity NPD7090 Clinical (unspecified phase)
0.7306 Intermediate Similarity NPD6853 Approved
0.7306 Intermediate Similarity NPD6851 Approved
0.729 Intermediate Similarity NPD7224 Discontinued
0.729 Intermediate Similarity NPD7223 Discontinued
0.7288 Intermediate Similarity NPD7124 Phase 2
0.7282 Intermediate Similarity NPD7291 Discontinued
0.7277 Intermediate Similarity NPD6297 Approved
0.7264 Intermediate Similarity NPD5457 Discontinued
0.7258 Intermediate Similarity NPD7201 Clinical (unspecified phase)
0.7254 Intermediate Similarity NPD2971 Approved
0.7254 Intermediate Similarity NPD7310 Approved
0.7254 Intermediate Similarity NPD2968 Approved
0.7254 Intermediate Similarity NPD7311 Approved
0.7254 Intermediate Similarity NPD7312 Approved
0.7254 Intermediate Similarity NPD7313 Approved
0.7247 Intermediate Similarity NPD5297 Approved
0.7238 Intermediate Similarity NPD8158 Clinical (unspecified phase)
0.7238 Intermediate Similarity NPD4017 Approved
0.723 Intermediate Similarity NPD6997 Phase 2
0.7219 Intermediate Similarity NPD7802 Discontinued
0.7216 Intermediate Similarity NPD7309 Approved
0.7213 Intermediate Similarity NPD3382 Approved
0.7213 Intermediate Similarity NPD3384 Approved
0.7213 Intermediate Similarity NPD3383 Approved
0.7212 Intermediate Similarity NPD8153 Approved
0.7212 Intermediate Similarity NPD8152 Approved
0.7202 Intermediate Similarity NPD7132 Clinical (unspecified phase)
0.7196 Intermediate Similarity NPD2489 Approved
0.7196 Intermediate Similarity NPD27 Approved
0.719 Intermediate Similarity NPD7047 Phase 3
0.7182 Intermediate Similarity NPD4210 Discontinued
0.7175 Intermediate Similarity NPD7466 Approved
0.7171 Intermediate Similarity NPD7607 Clinical (unspecified phase)
0.7168 Intermediate Similarity NPD2492 Phase 1
0.7165 Intermediate Similarity NPD4577 Approved
0.7165 Intermediate Similarity NPD4578 Approved
0.7158 Intermediate Similarity NPD7109 Clinical (unspecified phase)
0.7158 Intermediate Similarity NPD7110 Phase 1
0.7151 Intermediate Similarity NPD4055 Discovery
0.7143 Intermediate Similarity NPD8051 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD4663 Approved
0.7129 Intermediate Similarity NPD7827 Phase 1
0.7129 Intermediate Similarity NPD7237 Clinical (unspecified phase)
0.7128 Intermediate Similarity NPD6618 Phase 2
0.7121 Intermediate Similarity NPD5525 Clinical (unspecified phase)
0.712 Intermediate Similarity NPD7945 Clinical (unspecified phase)
0.7114 Intermediate Similarity NPD2974 Approved
0.7114 Intermediate Similarity NPD6621 Clinical (unspecified phase)
0.7114 Intermediate Similarity NPD2975 Approved
0.7114 Intermediate Similarity NPD2973 Approved
0.7111 Intermediate Similarity NPD7447 Phase 1
0.7098 Intermediate Similarity NPD6996 Clinical (unspecified phase)
0.7094 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7093 Intermediate Similarity NPD4474 Approved
0.7093 Intermediate Similarity NPD4475 Approved
0.7091 Intermediate Similarity NPD6625 Approved
0.7081 Intermediate Similarity NPD6668 Clinical (unspecified phase)
0.7079 Intermediate Similarity NPD6748 Discontinued
0.7065 Intermediate Similarity NPD5582 Discontinued
0.7059 Intermediate Similarity NPD7975 Clinical (unspecified phase)
0.7056 Intermediate Similarity NPD7598 Phase 2
0.7035 Intermediate Similarity NPD5718 Phase 2
0.7033 Intermediate Similarity NPD6662 Clinical (unspecified phase)
0.7029 Intermediate Similarity NPD2200 Suspended
0.702 Intermediate Similarity NPD3349 Phase 2
0.7018 Intermediate Similarity NPD5752 Clinical (unspecified phase)
0.7016 Intermediate Similarity NPD2898 Approved
0.7015 Intermediate Similarity NPD6493 Phase 3
0.701 Intermediate Similarity NPD4580 Approved
0.6989 Remote Similarity NPD4585 Approved
0.6983 Remote Similarity NPD5754 Discontinued
0.6978 Remote Similarity NPD3647 Clinical (unspecified phase)
0.6976 Remote Similarity NPD2494 Approved
0.6976 Remote Similarity NPD3452 Approved
0.6976 Remote Similarity NPD2493 Approved
0.6976 Remote Similarity NPD3450 Approved
0.6966 Remote Similarity NPD7045 Clinical (unspecified phase)
0.6961 Remote Similarity NPD7212 Phase 2
0.6961 Remote Similarity NPD3124 Discontinued
0.6961 Remote Similarity NPD7213 Phase 3
0.695 Remote Similarity NPD2490 Approved
0.695 Remote Similarity NPD2488 Approved
0.695 Remote Similarity NPD3808 Clinical (unspecified phase)
0.6937 Remote Similarity NPD7942 Clinical (unspecified phase)
0.6935 Remote Similarity NPD6843 Phase 3
0.6935 Remote Similarity NPD6841 Approved
0.6935 Remote Similarity NPD6842 Approved
0.6923 Remote Similarity NPD1754 Clinical (unspecified phase)
0.6919 Remote Similarity NPD6876 Approved
0.6919 Remote Similarity NPD4678 Approved
0.6919 Remote Similarity NPD4675 Approved
0.6919 Remote Similarity NPD1337 Clinical (unspecified phase)
0.6919 Remote Similarity NPD6875 Approved
0.6908 Remote Similarity NPD7064 Clinical (unspecified phase)
0.6907 Remote Similarity NPD42 Phase 2
0.6907 Remote Similarity NPD6042 Phase 2
0.69 Remote Similarity NPD7235 Clinical (unspecified phase)
0.6898 Remote Similarity NPD5773 Approved
0.6898 Remote Similarity NPD5772 Approved
0.6879 Remote Similarity NPD2669 Clinical (unspecified phase)
0.6878 Remote Similarity NPD5604 Discontinued
0.6875 Remote Similarity NPD5242 Approved
0.6875 Remote Similarity NPD4582 Approved
0.6875 Remote Similarity NPD4583 Approved
0.6865 Remote Similarity NPD4005 Discontinued
0.6863 Remote Similarity NPD5564 Approved
0.6861 Remote Similarity NPD6723 Discontinued
0.6859 Remote Similarity NPD7199 Phase 2
0.6851 Remote Similarity NPD5241 Discontinued
0.6848 Remote Similarity NPD5976 Discontinued
0.6842 Remote Similarity NPD8245 Clinical (unspecified phase)
0.6842 Remote Similarity NPD7400 Phase 3
0.6836 Remote Similarity NPD6895 Approved
0.6836 Remote Similarity NPD6111 Discontinued
0.6836 Remote Similarity NPD6896 Approved
0.6834 Remote Similarity NPD5087 Clinical (unspecified phase)
0.6827 Remote Similarity NPD4004 Approved
0.6827 Remote Similarity NPD4002 Approved
0.6825 Remote Similarity NPD4581 Clinical (unspecified phase)
0.6823 Remote Similarity NPD4010 Discontinued
0.6809 Remote Similarity NPD2978 Approved
0.6809 Remote Similarity NPD2977 Approved
0.6808 Remote Similarity NPD3816 Phase 1
0.6808 Remote Similarity NPD3815 Phase 1
0.68 Remote Similarity NPD554 Clinical (unspecified phase)
0.6791 Remote Similarity NPD5089 Approved
0.6791 Remote Similarity NPD5090 Approved
0.6788 Remote Similarity NPD7184 Clinical (unspecified phase)
0.6776 Remote Similarity NPD7837 Clinical (unspecified phase)
0.6772 Remote Similarity NPD5977 Approved
0.6772 Remote Similarity NPD5978 Approved
0.6769 Remote Similarity NPD5940 Clinical (unspecified phase)
0.6769 Remote Similarity NPD7177 Discontinued
0.6751 Remote Similarity NPD6496 Clinical (unspecified phase)
0.6749 Remote Similarity NPD7296 Approved
0.6742 Remote Similarity NPD7119 Phase 2
0.674 Remote Similarity NPD4237 Approved
0.674 Remote Similarity NPD4236 Phase 3
0.6734 Remote Similarity NPD5917 Clinical (unspecified phase)
0.673 Remote Similarity NPD7584 Approved
0.6721 Remote Similarity NPD6667 Approved
0.6721 Remote Similarity NPD6666 Approved
0.6719 Remote Similarity NPD2042 Clinical (unspecified phase)
0.6719 Remote Similarity NPD2041 Clinical (unspecified phase)
0.6719 Remote Similarity NPD2904 Discontinued
0.6718 Remote Similarity NPD5602 Clinical (unspecified phase)
0.6713 Remote Similarity NPD8149 Discontinued

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data